CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BIASCI, DANIELE RAKOCEVIC, GORAN TOPTAS, BERKE CAGKAN DE SANTIAGO DOMINGOS DE JESUS, INES |
| description | The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le diagnostic d'un cancer ou d'une métastase associée. L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le traitement d'un cancer ou d'une métastase associée. L'invention concerne un nouveau récepteur antigénique chimérique ou une protéine de fusion de récepteur de lymphocytes T qui comprend un ou plusieurs domaines de liaison à un antigène associés au cancer qui sont utiles pour le traitement d'un cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3138550A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3138550A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3138550A13</originalsourceid><addsrcrecordid>eNrjZLBydvRzdg1ScAwO9nf2dAxxdVFw9AvxdPJ3iVRw9vcN8A_2DPH09wsGiroo-LqGePi7BCv4uymEBrvyMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0djQ2MLU1MDR0NjIpQAAF5jKG8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE</title><source>esp@cenet</source><creator>BIASCI, DANIELE ; RAKOCEVIC, GORAN ; TOPTAS, BERKE CAGKAN ; DE SANTIAGO DOMINGOS DE JESUS, INES</creator><creatorcontrib>BIASCI, DANIELE ; RAKOCEVIC, GORAN ; TOPTAS, BERKE CAGKAN ; DE SANTIAGO DOMINGOS DE JESUS, INES</creatorcontrib><description>The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le diagnostic d'un cancer ou d'une métastase associée. L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le traitement d'un cancer ou d'une métastase associée. L'invention concerne un nouveau récepteur antigénique chimérique ou une protéine de fusion de récepteur de lymphocytes T qui comprend un ou plusieurs domaines de liaison à un antigène associés au cancer qui sont utiles pour le traitement d'un cancer.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201105&DB=EPODOC&CC=CA&NR=3138550A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201105&DB=EPODOC&CC=CA&NR=3138550A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BIASCI, DANIELE</creatorcontrib><creatorcontrib>RAKOCEVIC, GORAN</creatorcontrib><creatorcontrib>TOPTAS, BERKE CAGKAN</creatorcontrib><creatorcontrib>DE SANTIAGO DOMINGOS DE JESUS, INES</creatorcontrib><title>CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE</title><description>The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le diagnostic d'un cancer ou d'une métastase associée. L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le traitement d'un cancer ou d'une métastase associée. L'invention concerne un nouveau récepteur antigénique chimérique ou une protéine de fusion de récepteur de lymphocytes T qui comprend un ou plusieurs domaines de liaison à un antigène associés au cancer qui sont utiles pour le traitement d'un cancer.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBydvRzdg1ScAwO9nf2dAxxdVFw9AvxdPJ3iVRw9vcN8A_2DPH09wsGiroo-LqGePi7BCv4uymEBrvyMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0djQ2MLU1MDR0NjIpQAAF5jKG8</recordid><startdate>20201105</startdate><enddate>20201105</enddate><creator>BIASCI, DANIELE</creator><creator>RAKOCEVIC, GORAN</creator><creator>TOPTAS, BERKE CAGKAN</creator><creator>DE SANTIAGO DOMINGOS DE JESUS, INES</creator><scope>EVB</scope></search><sort><creationdate>20201105</creationdate><title>CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE</title><author>BIASCI, DANIELE ; RAKOCEVIC, GORAN ; TOPTAS, BERKE CAGKAN ; DE SANTIAGO DOMINGOS DE JESUS, INES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3138550A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BIASCI, DANIELE</creatorcontrib><creatorcontrib>RAKOCEVIC, GORAN</creatorcontrib><creatorcontrib>TOPTAS, BERKE CAGKAN</creatorcontrib><creatorcontrib>DE SANTIAGO DOMINGOS DE JESUS, INES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BIASCI, DANIELE</au><au>RAKOCEVIC, GORAN</au><au>TOPTAS, BERKE CAGKAN</au><au>DE SANTIAGO DOMINGOS DE JESUS, INES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE</title><date>2020-11-05</date><risdate>2020</risdate><abstract>The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le diagnostic d'un cancer ou d'une métastase associée. L'invention concerne de nouveaux anticorps associés au cancer et de nouveaux fragments de liaison à un antigène qui sont utilisés dans le traitement d'un cancer ou d'une métastase associée. L'invention concerne un nouveau récepteur antigénique chimérique ou une protéine de fusion de récepteur de lymphocytes T qui comprend un ou plusieurs domaines de liaison à un antigène associés au cancer qui sont utiles pour le traitement d'un cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3138550A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A57%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BIASCI,%20DANIELE&rft.date=2020-11-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3138550A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |